Exicure Inc. (XCUR) - Koefisien rega marang bathi
The price history of Exicure, Inc. (XCUR) with the -0.80 metric demonstrates business development where nucleic acid synthesis is automated using high-precision robots. Process efficiency is further enhanced by the rapid air delivery of small reagent batches without delays. The foundation of success lies in large-scale R&D investments, which have enabled Exicure, Inc. (XCUR) to become a leader in creating spherical nucleic acid-based drugs for genome editing.
Rincian analitis perusahaan Exicure Inc. (XCUR)
- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi pasar:
- data ekuitas miturut neraca:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Exicure, Inc.|XCUR - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Exicure Corp|XCUR - Gunggung utang perusahaan|Utang-utang marang aset resik Exicure, Inc.|XCUR - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Exicure|Indikator likuiditas cepet exicuretx.com
- data bathi resik lan rasio valuasi:
XCUR - Penghasilan resik|Prakiraan bathi perusahaan Exicure, Inc.|XCUR - Koefisien rega marang bathi|Rasio rega marang bathi mangsa ngarep Exicure Corp|XCUR - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Exicure, Inc.|XCUR - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Exicure|XCUR - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan exicuretx.com|XCUR - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Exicure, Inc.
Ringkesan analisis perusahaan:Exicure, Inc.
Assessing the financial stability of Exicure, Inc. (XCUR) requires an analysis of the market capitalization to net income ratio, which helps identify whether the asset is overpriced or faces low liquidity risks. By examining the company's price-to-earnings trend, an investor can see how an ultra-compact staffing structure and reliance on external contracts impact the speed of institutional capital exits without triggering a price collapse.
Analisis perusahaan pesaing
Tempus AI Inc (TEM) - Periode bali modal bisnis|Pangali P/E QGEN|Koefisien rega marang bathi Ionis Pharmaceuticals, Inc. IONS|Repligen Corp. - Koefisien rega marang bathi|Pangali P/E Avidity Corp RNA|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (genedx.com)|RARE: Pangali P/E|Kapitalisasi marang bathi Beam Therapeutics Inc (BEAM)|Koefisien rega marang bathi SRPT|TWST: Nilai perusahaan marang bathi resik|Pangali P/E TXG|Periode bali modal bisnis intelliatx.com|Rasio rega marang bathi Stoke Therapeutics, Inc. STOK|BLFS: Pangali rega marang bathi|Wave Life Sciences Corp - Pangali P/E|Maze Therapeutics Corp (MAZE) - Koefisien rega marang bathi|SION (Sionna Therapeutics Inc) - Koefisien rega marang bathi|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|Pangali rega marang bathi QURE (uniQure NV)|Pangali P/E MGTX|Koefisien rega marang bathi REGENXBIO Corp RGNX|Solid Biosciences Inc. - Koefisien rega marang bathi|Pangali P/E ocugen.com OCGN|PACB - Rasio rega marang bathi|Nilai perusahaan marang bathi resik BNTC (Benitec Biopharma Inc)|DSGN: Pangali P/E|Pangali rega marang bathi RCKT|Rasio rega marang bathi 4D Molecular Therapeutics|Pangali rega marang bathi LXEO (Lexeo)|Pangali P/E KRRO|Pangali P/E Editas Medicine Inc (EDIT)|Pangali P/E SLN (Silence Therapeutics Inc.)|ProQR (PRQR) - Kapitalisasi marang bathi|CDXS: Koefisien rega marang bathi|SGMO (sangamo.com) - Pangali rega marang bathi|NAUT: Pangali P/E|MGX - Periode bali modal bisnis|DTIL (Precision BioSciences, Inc.) - Pangali P/E|Koefisien rega marang bathi Generation Bio Corp (GBIO)|Koefisien rega marang bathi BOLD (Boundless Bio, Inc.)|Pangali P/E imunon.com (IMNN)|Rasio rega marang bathi Phio Pharmaceuticals Corp. PHIO|Nilai perusahaan marang bathi resik MBIO|TransCode - Pangali P/E|Kapitalisasi marang bathi Bionano Genomics, Inc.|APDN (Applied DNA Sciences) - Koefisien rega marang bathi|bluebirdbio.com - Nilai perusahaan marang bathi resik|IPA (ImmunoPrecise Antibodies Ltd) - Pangali P/E|Omega Therapeutics Inc (OMGA) - Periode bali modal bisnis|Rasio rega marang bathi Singular Genomics Systems Inc (OMIC)|Regulus - Pangali rega marang bathi|Pangali P/E SYRS (Syros Pharmaceuticals)|TBIO - Koefisien rega marang bathi|TCON: Koefisien rega marang bathi|Periode bali modal bisnis Unity Biotechnology Inc. UBX
